Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome
- PMID: 23705014
- PMCID: PMC3660316
- DOI: 10.1371/journal.pone.0064801
Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS) is a complex, heterogeneous disorder of uncertain etiology. Recent studies suggested that insulin resistance (IR) plays an important role in the development of PCOS. In the current study, we aimed to investigate the molecular mechanism of IR in PCOS. We employed genome-wide methylated DNA immunoprecipitation (MeDIP) analysis to characterize genes that are differentially methylated in PCOS patients vs. healthy controls. Besides, we also identified the differentially methylated genes between patients with PCOS-non-insulin resistance (PCOS-NIR) and PCOS-insulin resistance (PCOS-IR). A total of 79 genes were differentially methylated between PCOS-NIR vs. PCOS-IR patients, and 40 genes were differentially methylated in PCOS patients vs. healthy controls. We analyzed these differentially methylated genes by constructing regulatory networks and protein-protein interaction (PPI) networks. Further, Gene Ontology (GO) and pathway enrichment analysis were also performed to investigate the biological functions of networks. We identified multiple categories of genes that were differentially methylated between PCOS-NIR and PCOS-IR patients, or between PCOS patients and healthy controls. Significantly, GO categories of immune response were differentially methylated in PCOS-IR vs. PCOS-NIR. Further, genes in cancer pathways were also differentially methylated in PCOS-NIR vs. PCOS-IR patients or in PCOS patients vs. healthy controls. The results of this current study will help to further understand the mechanism of PCOS.
Conflict of interest statement
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3660316/bin/pone.0064801.g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3660316/bin/pone.0064801.g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3660316/bin/pone.0064801.g003.gif)
Similar articles
-
The role of miRNAs in polycystic ovary syndrome with insulin resistance.J Assist Reprod Genet. 2021 Feb;38(2):289-304. doi: 10.1007/s10815-020-02019-7. Epub 2021 Jan 6. J Assist Reprod Genet. 2021. PMID: 33405004 Free PMC article. Review.
-
Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.Mol Med Rep. 2020 May;21(5):2138-2150. doi: 10.3892/mmr.2020.11005. Epub 2020 Feb 26. Mol Med Rep. 2020. PMID: 32323770 Free PMC article.
-
Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies.Gynecol Endocrinol. 2016;32(5):343-53. doi: 10.3109/09513590.2015.1117069. Epub 2016 Jan 6. Gynecol Endocrinol. 2016. PMID: 27052492 Review.
-
Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome.Fertil Steril. 2015 Jul;104(1):145-53.e6. doi: 10.1016/j.fertnstert.2015.04.005. Epub 2015 May 5. Fertil Steril. 2015. PMID: 25956362
-
Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.J Clin Endocrinol Metab. 2012 Oct;97(10):E2016-21. doi: 10.1210/jc.2011-3441. Epub 2012 Aug 17. J Clin Endocrinol Metab. 2012. PMID: 22904171 Free PMC article.
Cited by
-
Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach.Cancers (Basel). 2023 Sep 21;15(18):4665. doi: 10.3390/cancers15184665. Cancers (Basel). 2023. PMID: 37760635 Free PMC article.
-
Effects of Mindfulness-Based Therapy on Clinical Symptoms and DNA Methylation in Patients with Polycystic Ovary Syndrome and High Metabolic Risk.Curr Issues Mol Biol. 2023 Mar 24;45(4):2717-2737. doi: 10.3390/cimb45040178. Curr Issues Mol Biol. 2023. PMID: 37185702 Free PMC article.
-
Multi-omics insights and therapeutic implications in polycystic ovary syndrome: a review.Funct Integr Genomics. 2023 Apr 20;23(2):130. doi: 10.1007/s10142-023-01053-9. Funct Integr Genomics. 2023. PMID: 37079114 Review.
-
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment.J Ovarian Res. 2023 Jan 11;16(1):9. doi: 10.1186/s13048-022-01091-0. J Ovarian Res. 2023. PMID: 36631836 Free PMC article. Review.
-
Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)-Searching for Epigenetic Factors.Int J Mol Sci. 2022 Nov 24;23(23):14663. doi: 10.3390/ijms232314663. Int J Mol Sci. 2022. PMID: 36498989 Free PMC article. Review.
References
-
- Legro RS, Strauss JF (2002) Molecular progress in infertility: polycystic ovary syndrome. Fertility and sterility 78: 569–576. - PubMed
-
- Diamanti-Kandarakis E, Kandarakis H, Legro RS (2006) The role of genes and environment in the etiology of PCOS. Endocrine 30: 19–26. - PubMed
-
- Hickey TE, Legro RS, Norman RJ (2006) Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab 91: 2789–2791. - PubMed
-
- van Houten E, Mcluskey A, Kramer P, Karels B, Themmen A, et al... (2011) Development of a mouse model with polycystic ovary syndrome. pp. P94.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous